VLNC Messages for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assess how messages about very low nicotine cigarettes (VLNCs) and related policies affect smoking habits and attitudes among adult smokers. Participants will receive either VLNCs with these messages or VLNCs with unrelated messages, such as water ads, to compare the effects. The trial targets current smokers who have smoked regularly in the past month and are open to trying new research cigarettes. The study involves weekly visits, surveys, and daily check-ins via text. As an unphased trial, it offers participants the opportunity to contribute to important research on smoking behaviors and potentially influence future public health policies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on smoking behavior and the use of very low nicotine cigarettes.
What prior data suggests that this messaging campaign and use of VLNCs is safe for adult smokers?
Research has shown that very low nicotine cigarettes (VLNCs) are generally easy for people to use. One study found that those who smoked VLNCs smoked fewer cigarettes daily and experienced less craving compared to those who smoked regular cigarettes. This suggests that VLNCs might be less satisfying, which is intended due to their lower nicotine content.
Another study examined how people understood messages about VLNCs. It found that people recognized these cigarettes had less nicotine and did not mistakenly believe they were completely safe. Instead, they viewed them as a potential aid in reducing smoking.
Overall, using VLNCs and the information about them appears safe for users. Research has not shown any major negative effects, making them a possible option for those who want to smoke less.12345Why are researchers excited about this trial?
Researchers are excited about the VLNC (Very Low Nicotine Content) messages for smoking because they offer a fresh approach to reducing tobacco dependence. Unlike traditional treatments, which often focus on nicotine replacement or pharmaceutical aids like patches or gum, this approach leverages messaging about reduced nicotine content. The VLNC with message campaign arm not only provides VLNC cigarettes but also actively educates participants through various media formats about the benefits of reduced nicotine, potentially enhancing motivation and awareness. This dual approach—combining product exposure with targeted messaging—could lead to more effective smoking cessation strategies by addressing both the physical and psychological aspects of smoking addiction.
What evidence suggests that this trial's treatments could be effective for reducing cigarette use?
Research has shown that messages about very low nicotine cigarettes (VLNCs) can change perceptions of smoking. One study found that these messages can reduce the belief that VLNCs are safer than regular cigarettes. This change is crucial for helping smokers cut down or quit. In this trial, participants in the "VLNC with message campaign" arm will receive VLNCs and be exposed to messaging about VLNCs and reduced nicotine policy. Another study demonstrated that specific messages can decrease false beliefs about the safety of reduced nicotine cigarettes. These findings suggest that using VLNCs along with clear messages can help reduce smoking by correcting misunderstandings and encouraging quitting. Meanwhile, participants in the "VLNC only" arm will receive VLNCs but will only be exposed to control messages, such as advertisements for bottled water.36789
Are You a Good Fit for This Trial?
This trial is for adult smokers, including those with recent serious psychological distress or low socioeconomic status. Participants must be willing to attend weekly study visits and complete daily surveys via text message.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants complete a baseline survey, provide expired breath CO sample, and receive a 1-week supply of full nicotine cigarettes
Randomization
Participants are randomized into treatment or control groups and receive a 14-day supply of VLNCs
Treatment
Participants attend weekly visits to complete questionnaires, provide expired CO samples, and receive VLNCs with or without messages
Follow-up
Participants are monitored for smoking behavior and attitudes after the treatment phase
What Are the Treatments Tested in This Trial?
Interventions
- Control message
- VLNC messages
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgia State University
Lead Sponsor
University of South Carolina
Collaborator
Emory University
Collaborator
National Cancer Institute (NCI)
Collaborator